{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:00:15Z","timestamp":1792735215049,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.neuropharm.2009.01.004","type":"journal-article","created":{"date-parts":[[2009,1,19]],"date-time":"2009-01-19T04:20:55Z","timestamp":1232338855000},"page":"788-797","source":"Crossref","is-referenced-by-count":49,"title":["Effects of antipsychotic drugs on MK-801-induced attentional and motivational deficits in rats"],"prefix":"10.1016","volume":"56","author":[{"given":"Tracie A.","family":"Paine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2009.01.004_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2006.01.019","article-title":"The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm","volume":"169","author":"Abdul-Monim","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-007-0808-x","article-title":"Cognitive\u2013disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","volume":"193","author":"Amitai","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00213-007-0959-9","article-title":"Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC","volume":"196","author":"Baviera","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.npp.1301136","article-title":"Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward","volume":"32","author":"Benaliouad","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib5","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.npp.1300893","article-title":"Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats","volume":"31","author":"Carli","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6","article-title":"Sustained attention deficits as markers of genetic susceptibility to schizophrenia","volume":"97","author":"Chen","year":"2000","journal-title":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies","volume":"161","author":"Correll","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1096-8628(20010108)105:1<11::AID-AJMG1045>3.0.CO;2-G","article-title":"Impaired attention as an endophenotype for molecular genetic studies of schizophrenia","volume":"105","author":"Cornblatt","year":"2001","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/1097-4679(199101)47:1<159::AID-JCLP2270470125>3.0.CO;2-O","article-title":"Recovery in neuropsychological functions during reductions in use of phencyclidine","volume":"47","author":"Cosgrove","year":"1991","journal-title":"Journal of Clinical Psychology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0074-7742(04)59019-0","article-title":"NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia","volume":"59","author":"Coyle","year":"2004","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2006.08.028","article-title":"Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance","volume":"175","author":"Dunn","year":"2006","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archpsyc.64.10.1115","article-title":"Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?","volume":"64","author":"Goldberg","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbr.2007.06.012","article-title":"Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat","volume":"184","author":"Grayson","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2006.09.062","article-title":"Effects of MK-801 on the expression of serine racemase and d-amino acid oxidase mRNAs and on the d-serine levels in rat brain","volume":"555","author":"Hashimoto","year":"2007","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-003-1549-0","article-title":"The 5-HT2A receptor antagonist M100,907 attenuates motor and impulsive-type behaviours produced by NMDA receptor antagonism","volume":"170","author":"Higgins","year":"2003","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0893-133X(97)00034-1","article-title":"Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat","volume":"17","author":"Jentsch","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib21","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1126\/science.277.5328.953","article-title":"Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine","volume":"277","author":"Jentsch","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib24","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/sj.npp.1300993","article-title":"Glial\u2013neuronal interactions are impaired in the schizophrenia model of repeated MK801 exposure","volume":"31","author":"Kondziella","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm1478","article-title":"Pathophysiologically based treatment interventions in schizophrenia","volume":"12","author":"Lewis","year":"2006","journal-title":"Nature Medicine"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00008877-200311000-00006","article-title":"Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits","volume":"14","author":"Madillo","year":"2003","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib28","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/sj.npp.1301661","article-title":"Detection of the moderately beneficial cognitive effects of low-dose treatment with haloperidol or clozapine in an animal model of the attentional impairments in schizophrenia","volume":"33","author":"Martinez","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.biopsych.2004.01.027","article-title":"A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book","volume":"55","author":"Mishara","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002130000486","article-title":"Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat","volume":"152","author":"Mobini","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib32","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Academy Press","year":"1996"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00213-002-1004-7","article-title":"Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats","volume":"161","author":"Nelson","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10258","article-title":"Gene expression profiling following chronic NMDA receptor blockade-induced learning deficits in rats","volume":"50","author":"O'Donnell","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s002130051055","article-title":"Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice","volume":"145","author":"O'Neill","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.biopsych.2006.11.017","article-title":"Sensitivity of the 5-choice serial reaction time task to the effects of various psychotropic drugs in Sprague\u2013Dawley rats","volume":"62","author":"Paine","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0149-7634(84)90006-X","article-title":"Phencyclidine (PCP): some human studies","volume":"8","author":"Pradhan","year":"1984","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib38","doi-asserted-by":"crossref","first-page":"S465","DOI":"10.1038\/bjp.2008.24","article-title":"Modelling prefrontal cortex deficits in schizophrenia: implications for treatment","volume":"153","author":"Pratt","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.pnpbp.2008.01.018","article-title":"Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats","volume":"32","author":"Rezvani","year":"2008","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00213-002-1154-7","article-title":"The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry","volume":"163","author":"Robbins","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2005.08.029","article-title":"A pharmacological model for psychosis based on N-methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities","volume":"59","author":"Rujescu","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bjp.0703171","article-title":"Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory","volume":"130","author":"Shroeder","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2009.01.004_bib43","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/sj.npp.1300732","article-title":"Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in the prefrontal cortex of conscious monkeys","volume":"30","author":"Tsukada","year":"2005","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390809000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T07:57:44Z","timestamp":1545465464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390809000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0028390809000033"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2009.01.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}